Our study demonstrated a novel paradigm of ESCC progression that involves the orchestration of cancer and non-cancer cells in the tumour micro- and macroenvironments by the Id1/IGF2/VEGF/VEGFR1 cascade (Fig. 9). The gene discussed is ID1; the disease is neoplasm.